Agilon Health Soars 10.59% on Earnings Growth Expectations

Agilon Health's stock surged 10.59% in pre-market trading on April 8, 2025, marking a significant rise that has caught the attention of investors and analysts alike.

Bernstein analyst Lance Wilkes maintained a Hold rating on Agilon Health, setting a price target of $3.30. This rating comes as the company is expected to see earnings growth in the coming year, with projections moving from a loss of $0.59 to $0.40 per share.

Royal Bank of Canada also boosted their target price on Agilon Health from $3.00 to $3.50, assigning an "outperform" rating. This positive outlook from major financial institutions suggests growing confidence in the company's future performance.